Abstract
Lung transplantation has been performed as a well-accepted therapy for patients with various end-stage lung diseases [1]. Nonetheless, the wide spread of lung transplantation is limited by the donor shortage resulting in increasing number of deaths on waiting lists [2, 3].
Historically, the first attempts of most of solid organ transplants were from donation after cardiac death donor (DCD)/non-heart-beating donor (NHBD) [4, 5]. Since the introduction of brain death criteria, organs have been retrieved from brain-dead (heart-beating) donors. However, as a result of increasing donor shortage, there is now a renewed interest in DCD (NHBD) lung transplantation [6, 7]. DCD (NHBD) is expected to become the major source of organ supply in countries especially where the concept of brain death is not widely accepted by the public.
This chapter aims to describe the relevant published experimental evidences and recent clinical experiences with lung transplantation from DCD (NHBD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg. 1999;230:362–70.
Oto T, et al. Registry of the Japanese society of lung and heart-lung transplantation: the official Japanese lung transplantation report 2012. Gen Thorac Cardiovasc Surg. 2013;61(4):208–11.
Sung RS, Galloway J, Tuttle-Newhall JE, Tuttle-Newhall JE, Mone T, Laeng R, et al. Organ donation and utilization in the United States, 1997–2006. Am J Transplant. 2008;8:922–34.
Kootstra G, Kievit J, Nederstigt A. Organ donors: heartbeating and non-heartbeating. World J Surg. 2002;26:181–4.
Hardy JD, Webb WR, Dalton Jr ML, Walker Jr GR. Lung homotransplantations in man. JAMA. 1963;186:1065–74.
Love RB, Stringham JC, Chomiak PN. Successful lung transplantation using a non-heart-beating donor. J Heart Lung Transplant. 1995;14:S88 (abstr).
Steen S, Sjőberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357:825–9.
Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–4.
Steen S, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–4.
Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin Chest Med. 2011;32:233–44.
de Antonio DG, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant. 2007;26:529–34.
Oto T, et al. A practical approach to clinical lung transplantation from a Maastricht category III donor with cardiac death. J Heart Lung Transplant. 2007;26:196–9.
Snell GI, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant. 2008;8:1282–9.
Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–200.
Steen S, Ingemansson R, Budrikis A, Bolys R, Roscher R, Sjőberg T. Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg. 1997;63:345–51.
Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant. 2008;27:78–85.
Oto T, Rabinov M, Griffiths AP, et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure? J Thorac Cardiovasc Surg. 2005;130:1446.
Levvey BJ, Westall GP, Kotsimbos T, Williams TJ, Snell GI. Definitions of warm ischemic time when using controlled donation after cardiac death lung donors. Transplantation. 2008;86:1702–6.
Oto T. Lung transplantation from donation after cardiac death (non-heart-beating) donors. Gen Thorac Cardiovasc Surg. 2008;56:533–8.
Van Raemdonck DE, Jannis NC, De Leyn PR, Flameng WJ, Lerut TE. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg. 1998;228:788–96.
Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant. 2004;23:3–10.
Rega FR, Neyrinck AP, Verleden GM, Lerut TE, Van Raemdonck DE. How long can we preserve the pulmonary graft inside the non-heart-beating donor? Ann Thorac Surg. 2004;77:438–44.
Rega FR, Jannis NC, Verleden GM, Flameng WJ, Lerut TE, Van Raemdonck DE. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor? J Heart Lung Transplant. 2003;22:1226–33.
Binns OA, DeLima NF, Buchanan SA, Mauney MC, Cope JT, Thies SD, et al. Impaired bronchial healing after lung donation from non-heart-beating donors. J Heart Lung Transplant. 1996;15:1084–92.
Miyoshi K, Oto T, Otani S, et al. Effect of donor pre-mortem hypoxia and hypotension on graft function and start of warm ischemia in donation after cardiac death lung transplantation. J Heart Lung Transplant. 2011;30:445–51.
Otani S, Oto T, Kakishita T, et al. Early effects of the ex vivo evaluation system on graft function after swine lung transplantation. Eur J Cardiothorac Surg. 2011;40:956–61.
Yeung JC, Cypel M, Machuca TN, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant. 2012;31:1120–6.
Geudens N, Van de Wauwer C, Neyrinck AP, Timmermans L, Vanhooren HM, Vanaudenaerde BM, et al. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant. 2007;26:1326–32.
Oto T, Calderone A, Pepe S, Snell G, Rosenfeldt F. High-flow endobronchial cooled humidified air protects non-heart-beating donor rat lungs against warm ischemia. J Thorac Cardiovasc Surg. 2006;132:413–9.
Yoshida S, Sekine Y, Shinozuka N, Satoh J, Yasufuku K, Iwata T, et al. The efficacy of partial liquid ventilation in lung protection during hypotension and cardiac arrest: preliminary study of lung transplantation using non-heart-beating donors. J Heart Lung Transplant. 2005;24:723–9.
Wittwer T, Franke UF, Sandhaus T, Groetzner J, Strauch JT, Wippermann J, et al. Endobronchial donor pre-treatment with ventavis: is a second administration during reperfusion beneficial to optimize post-ischemic function of non-heart-beating donor lungs? J Surg Res. 2006;136:136–42.
Chen F, Nakamura T, Fujinaga T, Zhang J, Hamakawa H, Omasa M, et al. Protective effect of a nebulized beta2-adorenoreceptor agonist in warm ischemic-reperfused rat lungs. Ann Thorac Surg. 2006;82:465–71.
Egan TM, Hoffmann SC, Sevala M, Sadoff JD, Schlidt SA. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant. 2006;25:110–9.
Takashima S, Koukoilis G, Inokawa H, Sevala M, Egan TM. Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors. J Thorac Cardiovasc Surg. 2006;132:132–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Oto, T. (2014). DCD for Lung Transplantation. In: Asano, T., Fukushima, N., Kenmochi, T., Matsuno, N. (eds) Marginal Donors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54484-5_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-54484-5_6
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54483-8
Online ISBN: 978-4-431-54484-5
eBook Packages: MedicineMedicine (R0)